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ABSTRACT
Background. Preoperative staging of patients with colo-
rectal carcinoma (CRC) has the potential beneﬁt of altering
treatment options when metastases are present. The clinical
value of chest computed tomography (CT) in staging
remains unclear.
Materials and Methods. All patients who undergo colo-
rectal surgery in our hospital are prospectively registered,
including patient, treatment, and histopathological charac-
teristics; outcome; and follow-up. Since January 2007,
routine preoperative staging CT of chest and abdomen for
patients with CRC has been performed as part of our
regional guidelines. In this observational cohort study, an
analysis on outcome was done after inclusion of 200 con-
secutive patients.
Results. Synchronous metastases were present in 60
patients (30%). Staging chest CT revealed pulmonary
metastases in 6 patients, with 1 false positive ﬁnding. In 50
patients indeterminate lesions were seen on chest CT
(25%). These were diagnosed during follow-up as true
metastases (n = 8), bronchus carcinoma (n = 2), benign
lesions (n = 25), and remaining unknown (n = 15). Ulti-
mately, synchronous pulmonary metastases were diagnosed
in 13 patients (7%), in 6 patients conﬁned to the lung (3%).
In none of the patients the treatment plan for the primary
tumor was changed based on the staging chest CT.
Conclusion. The low incidence of pulmonary metastases
and minimal consequences for the treatment plan limits the
clinical value of routine staging chest CT before operation.
It has several disadvantages such as costs, radiation expo-
sure, and prolonged uncertainty because of the frequent
ﬁnding of indeterminate lesions. Based on this study, a
routine staging chest CT in CRC patients is not advocated.
INTRODUCTION
Preoperative staging of patients with colorectal carci-
noma (CRC) has the potential beneﬁt of altering treatment
options when metastases are found. Synchronous metasta-
ses are usually detected in the liver, lung, and peritoneal
cavity. Staging with abdominal computed tomography
(CT) for liver metastases has resulted in various new
approaches aimed at increasing the chance of curative
treatment. It seems a logical next step to apply this
approach on synchronous pulmonary metastases as well.
Preoperative staging with CT of chest and abdomen in a
routine ‘‘one-stop shop’’ setting also has a logistical
advantage, saving time for both patient and physician. The
clinical beneﬁt of a staging chest CT, however, has been
controversial. There are few studies describing the outcome
and clinical relevance of a staging chest CT.
1–5 The main
problem of staging with chest CT lies in the frequent
ﬁnding of indeterminate lesions (20%–30%). These lesions
are usually difﬁcult to determine and seldom malignant
(10%–20%).
1,3 The main advice is not to delay treatment
of the primary tumor or of liver metastases when indeter-
minate lesions are found.
2,3,6 The outcome can be debated,
because in most of these studies the number of patients was
limited or the studies were carried out more then 10 years
ago. Accurate staging is increasingly important in the
oncological multidisciplinary treatment plan of CRC.
Rapid technical advancements and increasing knowledge
resulting from histopathological correlation studies
enhance the determination of pulmonary anomalies on
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7,8 For these reasons, routine staging with
abdominal and chest CT was decided upon as a part of our
regional guidelines for colorectal cancer. The aim of this
study was to analyze the outcome and clinical beneﬁt of
routine staging with chest CT after inclusion of a consec-
utive series of 200 patients with colorectal cancer.
METHODS
The Medical Spectrum Twente is a large teaching hos-
pital in the Eastern part of the Netherlands that functions as
a referral center for liver and lung surgery. All patients
operated on in our hospital for CRC are prospectively
registered in a database designed for colorectal surgery,
including patient, treatment, and histopathological charac-
teristics; outcome; and follow-up. Since January 2007,
routine preoperative staging CT of chest and abdomen for
patients with CRC has been performed as part of our
regional CRC guidelines, when feasible. An analysis on
beneﬁt was intended after inclusion of 200 patients with
staging CT of chest and abdomen as a prospective obser-
vational cohort study.
All patients with colon and rectal cancer presented to our
department, also those with an urgent or acute presentation,
were included. When a staging CT scan could not be per-
formedbeforeoperationbecauseofacutecircumstances,the
scan was done within 1 month after the operation. Patients
with rectal cancer at 0–10 cm from the anal verge were
additionally staged with a pelvic MRI for estimation of the
localinvasion(cTNstage).InthecasesofcT4tumorsorcT3
tumors with a distance\1 mm from the mesorectal fascia,
a long schedule of chemoradiation consisting of 25 9 2G y
combined with oral capecitabine was given followed by
surgery 6–8 weeks later. In the cases of cT3 tumors with a
distance of[1 mm from the mesorectal fascia, a short
schedule radiotherapy consisting of 5 9 5 Gy was given,
followed by surgery the following week. Both according to
the Dutch guidelines for rectal cancer.
A CT scan of chest and abdomen was performed on a
16- and 64-slice scanner (Toshiba Aquillion 16 and 64)
after intravenous contrast injection (visipaque 320, 90 mL,
3 mL/s.), in the portal venous phase, with a slice thickness
of 1 mm and a reconstruction of 0.8 mm. Lesions were
evaluated on density, number of lesions, morphology,
localization, and size. The lesions found on chest CT were
deﬁned by the radiologists as benign, malignant, or inde-
terminate. Indeterminate lesions are deﬁned as lesions seen
on chest CT that could not be judged by the radiologist as
either benign or malignant.
Follow-up was done for all patients when feasible
and consisted of 3-monthly visits with carcinoembry-
onic antigen (CEA) measurements, according to the
national guidelines. Indeterminate pulmonary lesions were
reevaluated during follow-up, with consideration of indi-
vidual patients’ circumstances. The deﬁnitive diagnosis of
pulmonary metastases was based on imaging (aspect and
growth rate on CT and/or PET scanning) or histological
conﬁrmation. Indeterminate pulmonary lesions were con-
sidered benign when there were no signs of malignant
growth on repeat chest CT and no increase in CEA after at
least 1 year of follow-up.
RESULTS
The 200 patients were included between January 2007
and August 2008 (Table 1). Elective procedures were done
on 164 patients (81%). Urgent or acute procedures were
done on 36 patients (19%), of whom 16 patients had a
staging CT after the surgical procedure. Findings during
follow-up till July 2009 were taken into the analysis.
Synchronous metastases in the liver, lung and/or peri-
toneal cavity were found in 60 patients of the study group
(30%) (Table 2). Pulmonary metastases were diagnosed on
the initial chest CT in 6 patients (3%). In 1 of these 6
patients the pulmonary lesion turned out to be benign after
resection. Indeterminate lesions were seen on 50 staging
chest CTs (25%) (Fig. 1). Additional diagnostic procedures
done during follow-up for indeterminate lesions were a
repeat chest CT scan in 29 patients, a PET scan in 11
patients, and a bronchoscopy and percutaneous needle
biopsy in 4 patients (Table 3). In 2 patients the percutane-
ous needle biopsy resulted in a small pneumothorax; in 1 of
4 patients a deﬁnite histological diagnosis could be made. In
8 patients the indeterminate lesions were diagnosed as
pulmonary metastases (16%), in 2 patients as primary
bronchus carcinoma, in 25 patients as benign lesions, and in
15 patients no diagnosis was made (Fig. 1). The time to
ﬁnal diagnosis of the indeterminate lesions took 3 months
up to 1 year after resection of the primary tumor.
Ultimately, 13 of the 200 study patients had synchro-
nous pulmonary metastases (7%) (Tables 2 and 4). In 6
patients the metastases were conﬁned to the lung (3%). Of
these 6 patients, 4 had no mesenterial lymph node metas-
tases at the primary tumor site. The prevalence of
synchronous lung metastases was higher in patients with
rectal cancer (0–15 cm from the anal verge) (7 of 71, 10%)
than in patients with colon cancer (6 of 129, 5%). Three
patients with rectal tumors who had neoadjuvant treatment
(radiation or chemoradiation) turned out to have lung
metastases (3 of 40, 8%) (Table 4). From the 47 patients
with liver metastases, 6 patients also had lung metastases
(13%). In 2 of 6 patients who had a conventional chest
x-ray as well, the metastasis were visible on chest x-ray.
In none of the patients with either lung metastases or
indeterminate lesions was the neoadjuvant or operative
plan for the primary tumor changed. In 2 patients, intended
2046 I. Grossmann et al.curative metastasectomy of true pulmonary metastases was
done; both patients had recurrent disease within 10 months
after resection.
DISCUSSION
As in preceding studies, this study shows the limited
clinical value of a routine preoperative staging chest CT in
colorectal cancer patients. The incidence of lung metasta-
ses is low (7%), especially those that are conﬁned to the
lung (3%). Only in 5 patients were lung metastases diag-
nosed before treatment of the primary tumor (2.5%).
Indeterminate lesions on chest CT are frequently found (in
25% of patients), and discrimination between benign and
malignant lesions is often difﬁcult. Only a minority turn
out to be metastases (16%). Staging with chest CT did not
result in a change of the treatment plan for the primary
tumor, nor did it result in curative treatment of pulmonary
metastases. It does cause diagnostic dilemmas and pro-
longed uncertainty and requires resources.
The clinical relevance of staging on distant metastases is
highly dependent on the consequences for the treatment
plan. Colorectal surgery knows a considerable morbidity
and mortality, which can be reduced when the presence of
incurable disease is diagnosed before the operation. For
asymptomatic patients with widespread metastases, only
chemotherapeutic treatment might be preferable. Also in
symptomatic patients with incurable disease, treatment
alternatives such as stenting for impending bowel
obstruction, limited surgery with only colostomy, or radi-
ation therapy in bleeding rectal tumors might be better
alternatives. Curable metastases found on the staging CT
can result in alternative strategies such as neoadjuvant
chemotherapy, a ‘‘liver-ﬁrst’’ approach, or simultaneous
resections. Intended curative resection of synchronous liver
metastases can be done in an estimated 25%–40% of
patients.
9,10 Consequently, accurate staging before resec-
tion of colorectal cancer has become a requirement for
optimal oncological treatment. Abdominal CT is a very
reliable diagnostic tool for liver metastases and has proven
to be better than noncontrast-enhanced ultrasound.
9,11,12
However, where accurate staging of the liver has resulted
in changes in treatment plans and possible favorable out-
come, this does not seem to be true for pulmonary staging
in this study. Several reasons were found that contribute to
the suggested difference between synchronous liver and
lung metastases. The incidence of lung metastases is much
lower (7%), and the curative options for synchronous lung
metastases are very limited or may be even nonexis-
tent.
13–15 This might be due to the bad prognosis of
synchronous pulmonary metastases as an expression of
tumor behavior, as has been suggested by other
authors.
13–15 Metastases conﬁned to the lung are rare (3%)
and limits the value of a routine staging chest CT when no
metastases are found on the staging abdominal CT.
Small nodules are often seen on chest CT and are usu-
ally benign, as was also found by Kronawitter et al. and
TABLE 1 Patient characteristics (n = 200)
Demographics Value %
Age
Mean 68 years
Median 70 years
Range 33–91 years
Gender
Female 83 42
Male 117 58
Rectal carcinoma 71 35
Rectum 0–5 cm 16
Rectum 5–10 cm 34
Rectum 10–15 cm 21
Colon carcinoma 129 65
Resection of the primary tumor 199 99
Neoadjuvant treatment
Neoadjuvant chemoradiation rectal carcinoma 33
a
Neoadjuvant radiotherapy (595Gy) rect. ca 7
a
Chemotherapy 1
b
Urgency
Elective procedure 164 81
Urgent and acute procedures 36 19
In-hospital mortality
Elective procedures 4 2
Urgent en acute procedures 4 11
AJCC stage based on pTNM (2002)
Stage 0
c 63
Stage I 22 11
Stage II 56 28
Stage III 56 28
Stage IV
d 60 30
Follow-up
Mean 19 months
Median 19 months
Range 12–30 months
a Neoadjuvant treatment was given to patients with rectal carcinoma
cT3-4N1-2 on MRI, located at 0–10 cm (lowest border of the tumor)
from the anal verge. From 40 patients who received neoadjuvant
radiation or chemoradiation, 11 had indeterminate lesions on chest CT
b This patient initially received palliative chemotherapy for asymp-
tomatic disease and incurable liver metastases. This strategy was
changed when the primary tumor became symptomatic
c Complete regression after neoadjuvant chemoradiation for rectal
carcinoma (cT3-4N1-2)
d In this table, metastases that were suspected on staging CT and
conﬁrmed during follow-up were classiﬁed as AJCC stage IV. Sus-
pected metastases that were resected and histologically benign were
classiﬁed as stage II or III disease. This overview therefore represents
the actual oncological status in the study cohort
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1,3 The difﬁculty with these lesions is that they
are usually too small (between 0.5 and 1 cm) to evaluate on
radiological characteristics such as density and shape.
Determination of the nature of these lesions has proven to
be rather difﬁcult. PET scanning has the same disadvantage
of a limited discriminative capacity for small lesions.
Percutaneous needle biopsies for small lesions can be
technically difﬁcult and are prone to sampling errors; when
the histological result does not show a malignancy, a
metastasis is still not excluded. It can, however, be harm-
ful, because of the risk of pneumothorax and bleeding
complications. In this study, it took several months up to
1 year after resection of the primary tumor before the
indeterminate lesions could be classiﬁed. Our deﬁnition of
a benign lesion, which is no growth and no serum-CEA
increase after 1 year, however, is a mere assumption and
TABLE 2 Localization of diagnosed synchronous distant metastases (n = 60)
Incidence Curative resection
Value % Value %
Liver metastases 47 24 13
a 28
Lung metastases 13 7 2
b 15
Peritoneal metastases 11 6 1
c 9
Localization of distant metastases
Liver 38 22 13
a 30
Liver and lung 5 3 0
Liver and peritoneal 3 2 0
Liver/lung/peritoneal 1 0.5 0
Lung 6 3 2
b
Lung/peritoneal 1 0.5 0
Peritoneal 6 3 1
c
This table shows the deﬁnite classiﬁcation after staging, operation, and additional testing in case of indeterminate lesions
a Only actual curative resections of liver metastases were counted
b Both patients had recurrent disease after curative resection at 5 and 10 months postoperatively
c HIPEC
CRC patients with staging
CT of chest and abdomen
(n = 200)
Indeterminate lung
lesions on chest CT
(n = 50) 25%
Diagnosed lung
metastases on chest CT
(n = 6) 3%
CRC
metastases
(n = 5)
Benign
(resection)
(n = 1)
Remain
indeterminate
(n = 15)
Reasons:*
No evaluation: 7
Deceased: 6
LTFU: 2
CRC
metastases
(n = 8)
Benign
lesions
(n = 25)
Bronchus
carcinoma
(n = 2)
FIG. 1 Outcome of staging chest CT in patients with CRC. All
numbers refer to the number of patients. Reasons: No evaluation, in
these patients the absence of presence of pulmonary metastases would
have no consequences for (further) treatment, such as with incurable
metastases on other locations or the wish of the patients to receive no
further treatment. Deceased, patients who died during hospital stay or
within 3 months after discharge. LTFU, lost to follow-up, both
patients were referred to other hospitals for reasons other then the
indeterminate pulmonary lesions
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other hand, the duration and absence of clinically relevant
disease does imply there is no need to try to ﬁnd these
lesions before treatment of the primary tumor. Staging with
chest CT during follow-up might be a better alternative.
The diagnostic difﬁculties of ﬁndings on chest CT are
also reﬂected in literature. The reported incidence of syn-
chronous pulmonary metastases of colorectal cancer varies
largely, from 3% to 18%.
1,3,4,6 This is likely inﬂuenced by
the applied deﬁnition of pulmonary metastases, which is
usually a derived deﬁnition because of a lack of obtainable
histological proof. In this study, neither the ‘‘gold’’ stan-
dard for false or true metastases was available. Because of
the criteria used for true metastases and study design, the
real incidence might be slightly underestimated. It is,
however, a close approximation of the number of patients
with clinically relevant lung metastases in a nonselected
population.
We agree with previous authors that small lesions on
chest CT (\1 cm) should be considered of limited clin-
ical relevance and ignored in choosing the initial
treatment plan.
1–3,6 The ﬁnding of large pulmonary
metastases might change the treatment plan, but these
kinds of metastases are rare and often visible on chest
x-ray. Few studies compared staging chest CT with chest
x-ray. Two studies compared a negative chest x-ray with
outcome on chest CT in preoperative staging, concluding
that a staging chest CT had little to no additional value.
1,6
One other study compared ﬁndings on staging chest x-ray
with chest CT.
2 This study showed that in 4 of 7 patients
the pulmonary metastases were visible on chest x-ray.
This number is comparable to the 2 of 6 visible metas-
tases on chest x-ray in this study.
Concerning the change of treatment plan in cases of
resectable liver metastases, pulmonary staging with chest
CT seems the best, most sensitive option to exclude
extrahepatic disease. Evaluation of consequences for
hepatic metastasectomy was not the aim of this study, and
the patient group is too small to draw conclusions; in the 5
patients with synchronous liver and lung metastases, the
liver metastases were not resectable. Povoski et al. did
study this speciﬁc patient group and concluded that chest
CT had only minimally improved detection of malignant
lesions of the lung over chest x-ray.
6
TABLE 3 Additional diagnostic tests for indeterminate lesions
(patients with indeterminate pulmonary lesions [n = 50])
Patients (n)
Regular follow-up without additional diagnostics 9
Repeat chest CT scan 29
PET scan 11
Bronchoscopy 4
Percutaneous needle biopsy 4
Multiple diagnostic procedures were usually done in a single patient
TABLE 4 Characteristics of the 13 patients with lung metastases
Localization
primary tumor
Neoadjuvant treatment Localization
synchronous metastases
Size and
number
Urgency pTN
Immediate diagnosis cT
Patient 1 Sigmoid – None Liver/lung/peritoneal 5 mm, M Elective pT4N2
Patient 2 Colon ascendens – None Lung 10 mm, M Urgent pT4N1
Patient 3 Colon descendens – None Liver and lung 80 mm, S Elective pT3N0
Patient 4 Rectum 10–15 cm – None Lung and peritoneal 9 mm, M Urgent pT4N2
Patient 5 Rectum 10–15 cm – None Liver and lung 25 mm, M Urgent pT3N2
Delayed diagnosis
Patient 6 Rectum 10–15 cm – None Lung 7 mm, S Elective pT3N0
Patient 7 Rectum 10–15 cm – None Liver and lung 9 mm, M Elective pT4N2
Patient 8 Rectum 0–5 cm cT4 RCT Liver and lung 4 mm, S Elective ypT4N0
Patient 9 Sigmoid – None Lung 10 mm, M Urgent pT3N0
Patient 10 Coecum – None Liver and lung 4 mm, S Elective pT4N2
Patient 11 Sigmoid – None Lung 47 mm, S
a Elective pT3N0
Patient 12 Rectum 0–5 cm cT3 RCT Lung 25 mm, M
a Elective ypT0N0
Patient 13 Rectum 5–10 cm cT3 RT Lung 11 mm, M Elective pT3N1
Immediate diagnosis diagnosed on staging CT, Delayed diagnosis diagnosed after additional diagnostic procedures, RCT chemoradiation,
RT short course radiotherapy (5 9 5 Gy), cT cT stage on pelvic MRI
Size: largest pulmonary lesion on the staging CT. Number: either single (S) or multiple (M)
a These lesions were primarily diagnosed as primary bronchus carcinoma; histology showed they were CRC metastases
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beneﬁt from a staging chest CT instead of chest x-ray, for
instance, patients with compromised health who are about
to undergo major surgical procedures for hepatic or per-
itoneal metastases or patients who will receive
neoadjuvant treatment for rectal cancer. The latter group
would especially beneﬁt because pulmonary metastases
seem to occur more often in rectal cancer than in colon
cancer and the operative procedure might be more
extensive. In our study, the proportion of patients with
rectal cancer, especially located 0–10 cm from the anal
verge, is too small to draw straightforward conclusions for
this speciﬁc group but deserves further study. It is,
however, likely the same problem with indeterminate
lesions on chest CT will occur. Future studies on imaging
techniques with a higher discriminative capacity for small
pulmonary nodules remain required to improve staging in
high-risk patient groups.
Relevant disadvantages other than the diagnostic difﬁ-
culties of routine chest CT are the signiﬁcant radiation
exposure and costs; routine staging with CT of the chest
together with CT of the abdomen is twice as expensive and
induces twice as much radiation exposure. When indeter-
minate lesions are seen, it may further cause a prolonged
period of uncertainty, unnecessary anxiety for patients and
relatives and possibly lead to a delay in neoadjuvant, sur-
gical, and adjuvant treatment. The need for additional
diagnostic procedures such as repeat chest CTs with a
summative radiation exposure, PET scanning, or percuta-
neous needle biopsies, further increases costs and possible
harm to the patient.
To conclude, in our opinion routine staging of colo-
rectal cancer patients with chest CT is not advocated
based on these study results. We believe that deﬁning
high-risk patient groups and predictive factors for pul-
monary metastases followed by either immediate
staging in selected patients or ‘‘delayed’’ staging with
chest CT during follow-up might be a better and less
expensive alternative to identify patients with pulmonary
metastases.
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